To hear about similar clinical trials, please enter your email below
Trial Title:
Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies
NCT ID:
NCT05916378
Condition:
Breast Cancer
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Genomic Testing
Precision Breast Cancer Care
Precision Medicine
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Prospective
Summary:
The purpose of this study is to identify the barriers, and the extent of said barriers,
to genomic testing for breast cancer patients among low-income and minority populations,
particularly throughout Northern California. The investigators have created a survey that
is available online for any patient with cancer to fill out voluntarily regarding their
experiences to date. The survey is available at:
https://stanforduniversity.qualtrics.com/jfe/form/SV_7VElf8oesWcB3bE
Detailed description:
The study has two main data-collecting phases. In phase 1, the investigators will engage
multilevel stakeholders to respond to a survey assessing experience with and perceptions
of genomic testing and its accessibility for patients with breast cancer in California.
In phase 2, selected and interested survey participants who voluntarily provide their
contact information on the survey will be asked to participate in an in-depth 1:1
semi-structured interview to explore disparities in genomic testing for breast cancer
more closely. The investigators will then utilize their findings from both phases to
present aggregate findings to an Expert Panel and Community Advisory Board and work
together to develop policy recommendations. The policy recommendations will then be
presented to policy makers, with the aim of identifying sustainable solutions that
address breast cancer treatment and outcome disparities throughout Northern California.
Criteria for eligibility:
Study pop:
We expect to recruit 150 participants for enrollment in phase 1. These participants will
include 100 patients diagnosed with breast cancer and 50 caregivers. In phase 2, we
expect to recruit 55 of our phase 1 survey participants to complete a one-time one-on-one
in-depth interview.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- The patients must be 18 years or older.
- Patients who opt in to complete the survey.
- Patients must have the capacity to verbally consent for the interview.
Exclusion Criteria:
- Patients who under the age of 18 years old.
Gender:
All
Minimum age:
18 Years
Maximum age:
99 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Stanford University School of Medicine
Address:
City:
Stanford
Zip:
94305
Country:
United States
Start date:
May 22, 2023
Completion date:
October 31, 2024
Lead sponsor:
Agency:
Stanford University
Agency class:
Other
Collaborator:
Agency:
The Latino Cancer Institute
Agency class:
Other
Source:
Stanford University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05916378
